Topics
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Contact Us
|
About IDSA
|
Membership
|
Member Networking
|
Find a Member
Log In
|
Register
Topics of Interest
Antimicrobial Resistance
Bioterrorism
Emerging Infections
Global ID
Hepatitis C
HIV
Immunization
Influenza
Lyme Disease
Manage Your Practice
Physician Payments
Billing & Coding
Quality Improvement
Value of ID Specialists
Health Information Technology
Medicare & Your Practice
Forms & Documents
Access and Reimbursement
Practice Management Listserve
HR & Staffing
Drug Shortages
Guidelines/Patient Care
IDSA Practice Guidelines
Guideline Methodology and Other Resources
For Patients & Public
Careers & Training
ID/HIV Career Center
Student & Resident Opportunities
Fellows-in-Training Center
Program Director Resources
Continuing Medical Education
Maintenance of Certification
Online Courses & Exams
Research & Funding Opportunities
International HIV Training Opportunities
Policy & Advocacy
Access & Reimbursement
Antimicrobial Resistance
Infection Prevention & Control
HIV/AIDS & Global TB
Immunizations & Vaccines
Emerging Infections & Biothreats
Research & Infrastructure
Workforce & Training
Federal Funding
News & Publications
Clinical Infectious Diseases
Journal of Infectious Diseases
IDSA News
HIVMA eNews
Science Speaks Blog
For Media
News Releases from IDSA
News from the Journals
Meetings
IDWeek 2013
IDWeek 2012
About Annual Meeting CME
Past Meetings
ID-Related Meetings Calendar
Annual Meeting Abstract Archives
View Menu
Guidelines
A-Z Index
Topics of Interest
Antimicrobial Resistance
Bioterrorism
Emerging Infections
Global ID
Hepatitis C
HIV
Immunization
Influenza
Lyme Disease
Manage Your Practice
Physician Payments
Billing & Coding
Quality Improvement
Value of ID Specialists
Health Information Technology
Medicare & Your Practice
Forms & Documents
Access and Reimbursement
Practice Management Listserve
HR & Staffing
Drug Shortages
Guidelines/Patient Care
IDSA Practice Guidelines
Guideline Methodology and Other Resources
For Patients & Public
Careers & Training
ID/HIV Career Center
Student & Resident Opportunities
Fellows-in-Training Center
Program Director Resources
Continuing Medical Education
Maintenance of Certification
Online Courses & Exams
Research & Funding Opportunities
International HIV Training Opportunities
Policy & Advocacy
Access & Reimbursement
Antimicrobial Resistance
Infection Prevention & Control
HIV/AIDS & Global TB
Immunizations & Vaccines
Emerging Infections & Biothreats
Research & Infrastructure
Workforce & Training
Federal Funding
News & Publications
Clinical Infectious Diseases
Journal of Infectious Diseases
IDSA News
HIVMA eNews
Science Speaks Blog
For Media
News Releases from IDSA
News from the Journals
Meetings
IDWeek 2013
IDWeek 2012
About Annual Meeting CME
Past Meetings
ID-Related Meetings Calendar
Annual Meeting Abstract Archives
Home
>
Policy & Advocacy
>
HIV/AIDS & Global TB
Print
ShareThis
Text Size
Access & Reimbursement
Antimicrobial Resistance
Infection Prevention & Control
HIV/AIDS & Global TB
HIV/AIDS Policy
Global Health Policy
Immunizations & Vaccines
Emerging Infections & Biothreats
Research & Infrastructure
Workforce & Training
Federal Funding
View All Letters on HIV/AIDS and TB
Search More Letters
12/21/2011
Joint IDSA/HIVMA Comments on Proposed CDC Organ Transplant Guideline (PDF)
IDSA and HIVMA's comments on CDC's Guideline for Reducing Transmission of HIV, Hepatitis B and Hepatitis C Virus through Solid Organ Transplantation call for: an amendment to federal transplantation law, clarification and consistency on MSM donor risk, and greater balance in the informed consent requirements. The Societies also propose a central tracking system and express concerns with donor screening recommendations.
10/18/2011
IDSA Opposes Attempts to Restore Ban on Use of Federal Funds for Syringe Exchange Programs (PDF)
IDSA joined physician and public health groups in sending a letter to President Obama urging him to oppose any attempts to restore the ban on use of federal funds for syringe exchange programs--a proven, life-saving approach to preventing transmission of HIV and hepatitis.
06/22/2011
IDSA, HIVMA Support Robust Global Infectious Diseases Funding (PDF)
IDSA, HIVMA and others wrote to House Appropriations Committee and State-Foreign Operations Subcommittee leaders requesting full funding of the President's FY 12 request for the U.S. Agency for International Development's malaria, tuberculosis and global HIV/AIDS initiatives.
09/24/2009
IDSA-HIVMA Needle Exchange Letter FY 2010 (PDF)
The HIV Medicine Association (HIVMA) and the Infectious Diseases Society of America (IDSA) are writing in support of a full repeal of the ban on federal funding for needle exchange programs in the final FY2010 Labor, Health and Human Services and Education appropriations bill.
01/21/2009
IDSA Urges Senate to Boost ID Public Health in Economic Stimulus Plan (PDF)
IDSA and HIVMA submitted proposals to Senate leaders urging the stimulus plan to include investments in public health infrastructure to address antimicrobial resistance, emerging infections, HIV/AIDS and tuberculosis.
09/05/2008
Letter to Senators McCain and Obama (PDF)
IDSA and HIVMA call on the presidential candidates to promote a science-based approach to public health policy, including immunization safety, sexuality education programs, access to clean syringes and needles for injecting drug users, and diagnosis and treatment of Lyme disease.
02/27/2008
IDSA Supports Global HIV/AIDS, TB and Malaria Legislation (PDF)
IDSA urges enactment of the U.S. Global Leadership on HIV/AIDS, TB and Malaria Act including strengthening TB vaccine research and development.
04/13/2004
Letter to HHS Secretary Thompson-Generics and PEPFAR
IDSA and HIVMA express grave concerns about current and proposed U.S. policies that effectively prohibit the purchase of generic fixed-dose combination antiretrovirals with funds allocated for the President’s Emergency Plan for AIDS Relief.
06/04/2002
IDSA Outlines its Research Priorities for NIH Director Elias Zerhouni, MD
IDSA and HIVMA supported the development of new therapeutics, vaccines, diagnostics and approaches; investigation of the chronic diseases/infectious agents link; global tuberculosis, malaria and HIV/AIDS research; research capacity/infrastructure building in resource-limited nations; the Fogarty International Center; international ID training opportunities; and domestic HIV/AIDS therapeutic research.
Subscribe for Updates
Average 0 out of 5
|
HIVMA
|
Contact Us
© Copyright IDSA 2013 Infectious Diseases Society of America
Full Site
Mobile Site